Articles Related to National Institute of Child Health and Human Development
Pharmacy Compounding Quality Control and Pharmaceutical Development Strategies for Seventeen alpha Hydroxyprogesterone Caproate in Prevention of Preterm Delivery
Seventeen alpha hydroxyprogesterone caproate (17-OHPC) is the only FDA-approved drug labeled for prevention of preterm delivery. This drug is also available as a compounded product from licensed compounding pharmacies. This article reviews the FDA approval history and pharmacy compounding quality control data of 17-OHPC, as well as briefly discusses possible future pharmaceutical development strategies for 17-OHPC.
Editorial Board Members Related to National Institute of Child Health and Human Development
PUNAM OHRI-VACHASPATI
Associate Professor
School of Nutrition and Health Promotion
Arizona State University
United States
School of Nutrition and Health Promotion
Arizona State University
United States
LEONID B. MARGOLIS
Visiting Professor
Ilia University
Republic of Georgia
Georgia
Ilia University
Republic of Georgia
Georgia